Helpline
Call 1.855.378.4373 to schedule a call time with a specialist or visit scheduler.drugfree.org
Helpline

The Latest News from Our Field

We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction. Sign up here to receive weekly updates straight to your inbox.

As federal funding dries up, states are increasingly looking to opioid settlement funds to fill the gaps, KFF Health News/CBS report.
The House passed a budget blueprint requiring $880 billion in cuts from the Energy and Commerce Committee, which would necessitate cuts to Medicaid.
A report found that DOL lacked critical tools to enforce parity compliance, furthering barriers to care.
Provisional CDC data shows about 87,000 overdose deaths Oct. 2023-Sept. 2024, down significantly from the previous year.
View our curated digest of the latest research news, including a study on whether chatbots provide reliable information on how to quit smoking.
Despite the proven effectiveness of buprenorphine to treat opioid use disorder, it continues to be under-utilized for a host of reasons.
A Kentucky county's use of opioid settlement funds highlights debate about what is needed for effective substance use prevention efforts.
A CDC report found that the rate of overdose deaths fell 4% from 2022 to 2023.
The Trump administration intends to defend the ACA's preventive services requirement in court, stressing the power of the HHS secretary.
View our curated digest of the latest research news, including a study on the effectiveness of school-based opioid education programs.
A legal loophole is allowing children with access to social media to see ads for marijuana, according to a new study.
High levels of an industrial chemical have been found in the illicit fentanyl supply in the United States, according to new research.
Despite the proven effectiveness of buprenorphine to treat opioid use disorder, it remains drastically underprescribed, The New York Times reports.
Find more of our must-reads in policy news, including a study finding that the opioid epidemic cost the U.S. $2.7 trillion in 2023.
View our curated digest of the latest research news, including an investigation of cardiovascular health outcomes associated with noncigarette tobacco products.
A new study links marijuana dependence to an increased risk of death, The New York Times reports.
Growing evidence suggests that newer weight-loss drugs such as semaglutide (Ozempic) may be useful in treating alcohol use disorder, NBC News reports.
The Council of Economic Advisers has released a study finding that the opioid epidemic cost the U.S. $2.7 trillion in 2023.
Find more of our must-reads in policy news, including tariffs targeting fentanyl trafficking concerns.
View our curated digest of the latest research news, including the development of a conceptual framework for the use of alternative payment models for substance use disorder prevention.
The Food and Drug Administration has approved a new non-opioid painkiller designed to eliminate the risk of addiction and overdose, AP reports.
State regulators around the country are facing challenges in keeping harmful substances such as pesticides, molds and heavy metals out of the supply of legal marijuana, NPR reports.
A new study finds most community crisis services did not expand after the launch of the 988 Suicide and Crisis Lifeline, potentially limiting the line’s effectiveness.
Find more of our must-reads in policy news, including RFK Jr.'s contentious HHS nomination hearings.
View our curated digest of the latest research news, including a review of prospective studies on the association between the age of cannabis use onset and later substance use problems.
1 2 3 262